Bostongene Corporation

États‑Unis d’Amérique

Retour au propriétaire

1-3 de 3 pour Bostongene Corporation Trier par
Recheche Texte
Marque
International - WIPO
Affiner par Reset Report
Date
2022 1
2021 2
Classe NICE
42 - Services scientifiques, technologiques et industriels, recherche et conception 3
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 3
09 - Appareils et instruments scientifiques et électriques 1
Résultats pour  marques

1.

PORTRAIT

      
Numéro d'application 1660862
Statut Enregistrée
Date de dépôt 2021-08-09
Date d'enregistrement 2021-08-09
Propriétaire BostonGene Corporation (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable software for displaying, recording, and analyzing medical data and medical images. Providing online, non-downloadable software for genetic and epigenetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online, non-downloadable software used for the sequencing and analyses of genomic, epigenomic, proteomic, and transcriptomic data; design, development and hosting online computer databases featuring scientific research information in the nature of genomic sequences for use in scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, epigenomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, epigenomics, proteomics, transcriptomics, and biochemistry; design, development and hosting online internet website portal featuring medical, genetic, epigenetic, genomic, epigenomic, proteomic, and transcriptomic research information and data for scientific, laboratory, and medical research and development purposes; providing online, non-downloadable software for displaying, recording, and analyzing medical data and medical images. Providing collected and analyzed medical information in the field of genetics, epigenetics, and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing, via online computer databases, medical information in the nature of genomic sequences for health care and medical purposes, namely, for tracking, matching, searching, testing, aggregating, and evaluating health status, and diagnosing diseases and gene mutations; providing, via an online internet website portal, medical information, namely, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes.

2.

BOSTONGENE

      
Numéro d'application 1625611
Statut Enregistrée
Date de dépôt 2021-02-03
Date d'enregistrement 2021-02-03
Propriétaire BostonGene Corporation (USA)
Classes de Nice  ?
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; medical laboratory services being medical research, in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, proteomic, and transcriptomic data; providing temporary use of online, non-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, and biochemistry; providing online, non-downloadable software for use in clinical trial data management and for management of electronic health records; hosting online computer databases of genomic sequences for medical scientific research, namely, for medical tracking, matching, searching, testing, aggregating, researching, and evaluating health status, for the purpose of diagnosing diseases and gene mutations. Genetic testing for medical purposes, specifically, genomic, proteomic, transcriptomic, and molecular medical testing for cancer and other diagnostic or treatment purposes; providing medical information, namely, providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical information, specifically, providing collected and analyzed medical information in the field of genomics, proteomics, transcriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing an online internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); providing an online internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations).

3.

MF PORTRAIT

      
Numéro d'application 1607721
Statut Enregistrée
Date de dépôt 2021-03-15
Date d'enregistrement 2021-03-15
Propriétaire BostonGene Corporation (USA)
Classes de Nice  ?
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Providing temporary use of online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, proteomic, and transcriptomic data; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, and biochemistry. Providing medical information, namely, providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing online computer databases of genomic sequences for medical scientific research, namely, for medical tracking, matching, searching, testing, aggregating, researching, and evaluating health status, for the purpose of diagnosing diseases and gene mutations (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations).